School of Life Sciences, Guangxi Normal University, Guilin, 541004, China.
Guangxi Universities Key Laboratory of Stem Cell and Biopharmaceutical Technology, Guangxi Normal University, Guilin, 541004, China.
J Mol Histol. 2022 Apr;53(2):239-256. doi: 10.1007/s10735-022-10063-z. Epub 2022 Feb 15.
Hepatic Stem/progenitor cells (HSPCs) have gained a large amount of interest for treating acute liver disease. However, the isolation and identification of HSPCs are unclear due to the lack of cell-specific surface markers. To isolate adult HSPCs, we used cell surface-marking antibodies, including CD49f and Sca-1. Two subsets of putative HSPCs, LinCD45Sca-1CD49f (CD49f) and LinCD45Sca-1CD49f (Sca-1) cells, were isolated from adult mice liver by flow cytometry. Robust proliferative activity and clonogenic activity were found in both CD49f and Sca-1 cells through colony-forming tests and cell cycle analyses. Immunofluorescence staining revealed that CD49f cells expressed ALB and CK-19 while Sca-1 cells expressed only ALB, indicating that CD49f cells were bipotential and capable of differentiating into hepatocyte and cholangiocyte. Consequently, PAS stain showed that differentiated CD49f and Sca-1 cells synthesised glycogen, indicating they could differentiate into functional hepatocytes. mRNA expression profile indicated that both CD49f and Sca-1 cells showed differential expression of genes that are associated with liver progenitor function such as Sox9 and EpCam. Moreover, two subsets of putative HSPCs were activated by DDC and we found that their abundance and proliferation increased with age. In summary, we hypothesized that CD49f cells were a type of potential HSPCs and may be utilised for clinical stem cell therapy.
肝干细胞/祖细胞(HSPCs)在治疗急性肝病方面引起了广泛关注。然而,由于缺乏细胞特异性表面标志物,HSPCs 的分离和鉴定仍不明确。为了分离成年 HSPCs,我们使用了细胞表面标记抗体,包括 CD49f 和 Sca-1。通过流式细胞术从成年小鼠肝脏中分离出两个潜在 HSPCs 亚群,LinCD45Sca-1CD49f(CD49f)和 LinCD45Sca-1CD49f(Sca-1)细胞。通过集落形成试验和细胞周期分析,发现 CD49f 和 Sca-1 细胞均具有强大的增殖活性和克隆形成活性。免疫荧光染色显示 CD49f 细胞表达 ALB 和 CK-19,而 Sca-1 细胞仅表达 ALB,表明 CD49f 细胞具有双潜能,能够分化为肝细胞和胆管细胞。因此,PAS 染色显示分化的 CD49f 和 Sca-1 细胞合成糖原,表明它们可以分化为具有功能的肝细胞。mRNA 表达谱表明,CD49f 和 Sca-1 细胞均表现出与肝祖细胞功能相关的基因的差异表达,如 Sox9 和 EpCam。此外,两种潜在 HSPCs 亚群被 DDC 激活,我们发现它们的丰度和增殖随年龄增长而增加。综上所述,我们假设 CD49f 细胞是一种潜在的 HSPCs,可能用于临床干细胞治疗。